VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 21, 2007) - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection CompanyTM, announced that the Company has been invited to present Allon's clinical progress and strategy for AL-108 at the 3rd Annual CNS Diseases Congress, June 25th to 26th, 2007, located at the Hilton Boston Back Bay Hotel, in Boston Massachusetts. The presentation by Dr. Bruce Morimoto, Allon's VP of Drug Development, is titled "Neuroprotection by AL-108, an Intranasal Peptide" and will take place on Monday June 25th at 9:30am EST.
